<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80440">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01686347</url>
  </required_header>
  <id_info>
    <org_study_id>2010/146/HP</org_study_id>
    <nct_id>NCT01686347</nct_id>
  </id_info>
  <brief_title>Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil</brief_title>
  <acronym>epidarc</acronym>
  <official_title>Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the investigators study is to demonstrate the association between fetal cardiac
      rhythm abnormalies after epidural analgesia and the maternal systemic transfer of
      ropivacaine and/or sufentanil.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Plasmatic concentrations compared maternal ropivacaine based on the presence of abnormal fetal heart rate</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Maternal Plasmatic concentrations of ropivacaine will be measured in mg / liter of maternal blood and the median of each group will be compared by paired Wilcoxon test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasmatic concentrations compared maternal sufentanil based on the presence of abnormal fetal heart rate</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Maternal Plasmatic concentrations of sufentanil will be measured in mg / liter of maternal blood and the median of each group will be compared by paired Wilcoxon test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Fetal Cardiac Rhythm Abnormalities</condition>
  <arm_group>
    <arm_group_label>fetal cardiac rhythm abnormally</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient at term, in spontanous labor with fetal cardiac rythm abnormally which occurs 30 minutes after the epidural analgesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient at term, spontaneous labor, without any fetal cardiac rhythm abnormalies during the 30 minutes after the epidural analgesia induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <arm_group_label>fetal cardiac rhythm abnormally</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or more

          -  nulliparous

             _ one fetus

          -  head first

          -  spontaneous labor

          -  epidural analgesia

          -  no fetal cardiac rhythm abnormalies before the epidural analgesia

          -  no active management of labor during 30 minutes after the epidural analgesia
             induction

          -  at term

          -  signature of the consent form

        Exclusion Criteria:

          -  pathological pregnancy

          -  low maternal blood pressure during the 30 minutes after the epidural analgesia

          -  uterin contraction which last for 5 minutes or more

          -  more than 6 uterin contractions during a 10 minutes period

          -  Ropivacaine contraindication

          -  sufentanil contraindication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>PIZZAGALLI franck, midwife</last_name>
    <phone>+33232888990</phone>
    <phone_ext>64286</phone_ext>
    <email>franck.pizzagali@chu-rouen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>centre hospitalier universitaire de Rouen, Hopital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>pizzagalli franck, widwife</last_name>
      <phone>0232888990</phone>
      <phone_ext>64286</phone_ext>
      <email>franck.pizzagali@chu-rouen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 6, 2014</lastchanged_date>
  <firstreceived_date>June 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidural analgesia</keyword>
  <keyword>fetal cardiac rythm</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>sufentanil</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
